Eventide Gilead Class I (ETILX)
| Fund Assets | 2.96B |
| Expense Ratio | 1.16% |
| Min. Investment | $100,000 |
| Turnover | 60.00% |
| Dividend (ttm) | 6.87 |
| Dividend Yield | 11.84% |
| Dividend Growth | 966.98% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 16, 2025 |
| Previous Close | 57.46 |
| YTD Return | 1.88% |
| 1-Year Return | 15.90% |
| 5-Year Return | 2.09% |
| 52-Week Low | 37.49 |
| 52-Week High | 59.50 |
| Beta (5Y) | n/a |
| Holdings | 70 |
| Inception Date | Feb 2, 2010 |
About ETILX
Eventide Gilead Fund Class I is an actively managed mutual fund focused on achieving long-term capital appreciation. The fund primarily invests in a diversified portfolio of equity securities, with a significant emphasis on U.S. mid-cap growth companies—typically firms positioned within the middle 20% of the U.S. equity market by capitalization and exhibiting robust growth prospects in areas such as earnings and sales. In addition, the fund may invest in companies of any size and can include international holdings, either directly or through American depositary receipts. Managed by Eventide Asset Management since 2008, the fund is recognized for its blend of traditional financial analysis with a commitment to positive societal impact and stakeholder value. Its portfolio is relatively concentrated, with a notable share allocated to top holdings in sectors like industrials, technology, and healthcare. The fund’s institutional share class caters primarily to investors seeking an actively managed, values-driven approach to growth equities, combining disciplined investment selection with a broader mission to align financial returns with the common good.
Performance
ETILX had a total return of 15.90% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.54%.
Top 10 Holdings
32.98% of assets| Name | Symbol | Weight |
|---|---|---|
| Xometry, Inc. | XMTR | 5.63% |
| Guardant Health, Inc. | GH | 4.93% |
| Mirum Pharmaceuticals, Inc. | MIRM | 3.60% |
| Toast, Inc. | TOST | 2.95% |
| US BANK MMDA - USBGFS 9 | n/a | 2.83% |
| Trane Technologies plc | TT | 2.75% |
| iRhythm Holdings, Inc. | IRTC | 2.74% |
| United Rentals, Inc. | URI | 2.59% |
| GE Vernova Inc. | GEV | 2.52% |
| Verona Pharma PLC | VRNA | 2.43% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $6.8724 | Dec 17, 2025 |
| Dec 13, 2024 | $0.6441 | Dec 16, 2024 |
| Dec 15, 2022 | $2.2812 | Dec 16, 2022 |
| Dec 16, 2021 | $4.2652 | Dec 17, 2021 |
| Dec 17, 2020 | $0.5114 | Dec 17, 2020 |
| Dec 17, 2019 | $1.3176 | Dec 17, 2019 |